6000万元买基金,9个月巨亏81%!A股公司,紧急报警
Sou Hu Cai Jing·2025-12-27 14:52

Core Viewpoint - Shengyuan Environmental reported significant losses from a wealth management product, with a cumulative loss of 81.54%, exceeding 10% of the annual net profit, which may impact the company's 2025 operating performance [1][4]. Group 1: Investment Details - The investment began between February and March 2025, with a total of 60 million yuan allocated to a private equity fund managed by Shenzhen Shenboxin Investment Management Co., Ltd. [3]. - The fund was classified as R4 level (medium to high risk) and included investments in equity, fixed income, futures, and derivatives [3]. - The fund contract included multiple risk control measures, such as limiting single asset investment to 25% of net assets and requiring monthly and quarterly disclosures of fund performance [3]. Group 2: Losses and Management Response - On December 9, the company attempted to redeem all fund shares, only to find that the fund's unit net value had plummeted from 0.9215 yuan to 0.2596 yuan, a drop of 71.83% [4]. - By December 25, the fund's unit net value further declined to 0.1846 yuan, resulting in a total loss of 46.92 million yuan [4]. - Following the discovery of the losses, the company established a special task force and communicated with the fund manager, who agreed to bear joint liability for the principal loss [4][5]. Group 3: Legal Actions and Violations - The company has reported the incident to law enforcement and the China Securities Regulatory Commission, while also requesting the fund manager to halt trading and liquidate all positions [5]. - Investigations revealed that the fund manager engaged in unauthorized trading and falsified net asset values, while the fund custodian failed to fulfill supervisory duties, leading to significant investor losses [4][5]. Group 4: Company Performance - Shengyuan Environmental's main business involves specialized treatment of urban solid and liquid waste, including waste incineration power generation and sewage treatment [6]. - In the first three quarters, the company achieved total revenue of 1.15 billion yuan, a year-on-year decrease of 0.67%, while net profit attributable to shareholders increased by 43.22% to 211 million yuan [6].